Aclarion (Aclarion) EV-to-EBIT : 0.00 (As of Jun. 22, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Aclarion EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aclarion's Enterprise Value is $0.00 Mil. Aclarion's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-5.18 Mil. Therefore, Aclarion's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Aclarion's EV-to-EBIT or its related term are showing as below:

During the past 5 years, the highest EV-to-EBIT of Aclarion was 0.26. The lowest was -4.49. And the median was -0.69.

ACONW's EV-to-EBIT is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 17.195
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Aclarion's Enterprise Value for the quarter that ended in Mar. 2024 was $0.00 Mil. Aclarion's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-5.18 Mil. Aclarion's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was %.

Aclarion EV-to-EBIT Historical Data

The historical data trend for Aclarion's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aclarion EV-to-EBIT Chart

Aclarion Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

-0.56

-0.64

Aclarion Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial											-0.78	-1.00	-0.74	-0.64	-0.17

Competitive Comparison of Aclarion's EV-to-EBIT

For the Health Information Services subindustry, Aclarion's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aclarion's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aclarion's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aclarion's EV-to-EBIT falls into.

Aclarion EV-to-EBIT Calculation

Aclarion's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.000	/	-5.184
	=	0.00

Aclarion's current Enterprise Value is $0.00 Mil.
Aclarion's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.18 Mil.

Aclarion (NAS:ACONW) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Aclarion's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-5.184	/	0
	=	%

Aclarion's Enterprise Value for the quarter that ended in Mar. 2024 was $0.00 Mil.
Aclarion's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.18 Mil.

Aclarion EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Aclarion's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Aclarion (Aclarion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aclarion Inc (NAS:ACONW) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

ACON:USA

Address

8181 Arista Place, Suite 300, Broomfield, CO, USA, 80021

Website

http://www.aclarion.com

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.